Outcome of liver transplantation for haemophilia

HPB

Volumn 13, Issue 1, 2011, Pages 40-45

  Yokoyama, Satoshi ^a   Bartlett, Adam ^a,b   Dar, Faisal S ^a   Heneghan, Michael ^a   O'Grady, John ^a   Rela, Mohamed ^a   Heaton, Nigel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

hemophilia; hepatitis C virus; hepatitis recurrence; human immunodeficiency virus; liver transplantation

Indexed keywords

BLOOD CLOTTING FACTOR; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLEEDING; END STAGE LIVER DISEASE; FOLLOW UP; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; SURVIVAL; TREATMENT OUTCOME;

EID: 78650356910     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00237.x     Document Type: Article

References (25)

1. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C,. (1994) The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 87: 555-561.
2. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. (1992) Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103: 317-322.
3. McCarthy M, Gane E, Pereira S, Tibbs CJ, Heaton N, Rela M, et al. (1996) Liver transplantation for hemophiliacs with hepatitis C cirrhosis. Gut 39: 870-875. (Pubitemid 27049094)
4. Wilde JT,. (2004) HIV and HCV coinfection in hemophilia. Hemophilia 10: 1-8. Review.
5. Lewis JH, Bontempo FA, Spero JA, Ragni MV, Starzl TE,. (1985) Liver transplantation in a hemophiliac. N Engl J Med 312: 1189-1190.
6. Wilde J, Teixeira P, Bramhall SR, Gunson B, Mutimer D, Mirza DF,. (2002) Liver transplantation in hemophilia. Br J Haematol 117: 952-956.
7. Gordon FH, Mistry PK, Sabin CA, Lee CA,. (1998) Outcome of orthotopic liver transplantation in patients with hemophilia. Gut 42: 744-749.
8. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ,. (1994) Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 84: 1020-1023.
9. Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, et al. (2004) Peginterferon 2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology 126: 1015-1023.
10. Patel H, Heathcote EJ,. (2009) When to treat and the benefits of treating hepatitis C in patients with hemophilia. Hemophilia 15: 20-32. Epub 2008 Oct 23. Review.
11. Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau JYN, et al. (1998) The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 28: 831-838.
12. Gane EJ, Lo SK, Riordan SM, Portmann BC, Lau JYN, Naoumov NV, et al. (1998) A randomised study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 27: 1403-1407.
13. Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, et al. (2003) Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 124: 642-650.
14. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334: 815-820.
15. Soriano V, Garcia-Samaniego J, Valencia E, Rodriguez-Rosado R, Munoz F, Gonzalez-Lahoz J,. (1999) Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drugusers. Eur J Epidemiol 15: 1-4.
16. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, et al. (2001) Hepatitis C virus infection-related morbidity and mortality among patients with HIV infection. Clin Infect Dis 33: 240-247.
17. Soto B, Sánchez-Quijano A, Rodrigo L, del Olmo JA, García-Bengoechea M, Hernández-Quero J, et al. (1997) HIV infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26: 1-5.
18. Makris M, Preston FE, Rosendaal FR, Underwood JCE, Rice KM, Triger DR,. (1996) The natural history of chronic hepatitis C in hemophiliacs. Br J Haematol 94: 746-752.
19. Rumi MG, De Filippi F, Santagostino E, Colombo M,. (2004) Hepatitis C in hemophilia: lights and shadows. Hemophilia 10 (Suppl. 4): 211-215. Review.
20. Franchini M, Nicolini N, Capra F,. (2006) Treatment of hepatitis C in hemophiliacs. Am J Hematol 81: 696-702. Review.
21. Dalladetsima J, Katsarou O, Touloumi G, Vgenopoulou S, Hatzakis A, Karafoulidou A,. (2002) Significance of immune status, genotype and viral load in the severity of chronic hepatitis C in HIV infected hemophilia patients. Hemophilia 8: 668-673.
22. Jain AKB, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, et al. (2002) The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 8: 841-845.
23. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. (2003) Kidney and liver transplantation in HIV-infected patients: a pilot safety and efficacy study. Transplantation 76: 370-375.
24. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. (2000) The Swiss HIV cohort study. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection. Lancet 356: 1800-1805.
25. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, et al. (2003) Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 9: 239-247.